What does iXensor Co., Ltd. do?

iXensor Co., Ltd. (6734.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6734.TWO's market cap?

iXensor Co., Ltd. (6734.TWO) has a market capitalization of approximately $259.5 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 6734.TWO pay a dividend?

No — iXensor Co., Ltd. (6734.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6734.TWO profitable?

iXensor Co., Ltd. (6734.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6734.TWO

iXensor Co., Ltd.

TWO·Medical, Devices · Healthcare

NT$6.25NT$0.05+0.81%

Market capNT$259.54M·Market closed·Aug 27 6:59 AM UTC

Price Chart

NT$6.25+NT$0.05 (+0.81%)today

−82.99%CAGR −29.84%

Select date range

FromTo

Jun 27, 2019Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

6734.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$26.67M

Net Income−NT$49.10M

Net Margin−184.1%

Operating Cash Flow−NT$47.96M

Capital ExpendituresNT$168.00K

Free Cash Flow−NT$48.13M

Return on Equity−571.5%

Return on Invested Capital−77.3%

Net DebtNT$6.96M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6734.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6734.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6734.TWO and 80,000+ other tickers.

About iXensor Co., Ltd.

iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest…

CEO: Yanyu Chen
Sector: Healthcare
Industry: Medical - Devices
Exchange: TWO
Employees: 50
Website: www.ixensor.com

Peers

Peers Tab

6744.TWO

Feng Chi Biotech Corp.

RBC Bioscience Corporation

Cap

NT$335.4M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6734.TWO

What does iXensor Co., Ltd. do?: iXensor Co., Ltd. (6734.TWO) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6734.TWO's market cap?: iXensor Co., Ltd. (6734.TWO) has a market capitalization of approximately $259.5 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 6734.TWO pay a dividend?: No — iXensor Co., Ltd. (6734.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6734.TWO profitable?: iXensor Co., Ltd. (6734.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.